New research data show HK532-IGF-1 cell therapy may be beneficial for Alzheimer’s disease

Written by Alexandra Thompson

Alzheimer’s disease (AD) is the most commonly diagnosed form of dementia, involving the parts of the brain that control thought, memory and language. As a neurodegenerative disease, it begins with mild memory loss and leads to loss of the ability to carry on a conversation and respond to the environment. With no known cure, an increasing prevalence and an aging population, there is a clear and urgent need for an effective treatment. In a poster presentation at the 2015 International Society for Stem Cell Research (ISSCR) Annual Meeting in Stockholm, Sweden, a team of researchers from the University of Michigan...

To view the full article, please register now for access

It's completely free